The Role Adjuvant Chemotherapy in Resected Stage 1 NSCLC with High Risk Factors: A Turkish Oncology Group Study


ERALP Y., AK N., Yilmazbayhan D., ÖZKAN B., FERHATOĞLU F., Demirkazik A., ...More

JOURNAL OF THORACIC ONCOLOGY, no.10, 2019 (SCI-Expanded, Scopus)